Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 27 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 10968205

    Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  2. US 10961200

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  3. US 10959984

    Methods for treating cancer with RORγ inhibitors

    The Regents of the University of California · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  4. US 10961232

    Substituted pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  5. US 10954228

    1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof

    NATIONAL INSTITUTES OF HEALTH, UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  6. US 10954237

    JAK inhibitors containing a 4-membered heterocyclic amide

    Theravance Biopharma R&D IP, LLC · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  7. US 10952996

    ALK5 inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  8. US 10952997

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  9. US 10947238

    Wee1 kinase inhibitors and methods of making and using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  10. US 10941183

    Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

    Protagonist Therapeutics, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  11. US 10941140

    IRAK inhibitors and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  12. US 10940141

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  13. US 10934332

    Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment

    The Regents of the University of California · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  14. US 10934274

    Quinoline derivatives as TAM RTK inhibitors

    Lead Discovery Center GmbH · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  15. US 10934302

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  16. US 10934299

    Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

    Valo Early Discovery, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  17. US 10934305

    SHMT inhibitors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  18. US 10927118

    Inhibitors of influenza virus replication and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  19. US 10927130

    Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

    Valo Early Discovery, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  20. US 10919877

    Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted
  21. US 10913753

    Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

    Valo Early Discovery, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  22. US 10912771

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  23. US 10913711

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted
  24. US 10912779

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted